PARP Inhibitor Veliparib and HDAC Inhibitor SAHA Synergistically Co-Target the UHRF1/BRCA1 DNA Damage Repair Complex in Prostate Cancer Cells

Journal of Experimental and Clinical Cancer Research - United Kingdom
doi 10.1186/s13046-018-0810-7
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

The PARP Inhibitor AZD2281 (Olaparib) Induces Autophagy/Mitophagy in BRCA1 and BRCA2 Mutant Breast Cancer Cells

International Journal of Oncology
Cancer ResearchOncology
2015English

PARP Inhibitor Re‑sensitizes Adriamycin Resistant Leukemia Cells Through DNA Damage and Apoptosis

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2018English

Synergistic Antitumour Activity of HDAC Inhibitor SAHA and EGFR Inhibitor Gefitinib in Head and Neck Cancer: A Key Role for ΔNp63α

British Journal of Cancer
Cancer ResearchOncology
2019English

RING Domain–deficient BRCA1 Promotes PARP Inhibitor and Platinum Resistance

Journal of Clinical Investigation
Medicine
2016English

HDAC Inhibitor SAHA Induces McPip1 Expression and Suppresses IL-6 Expression in Human OA Chondrocytes

Osteoarthritis and Cartilage
Sports MedicineRheumatologyOrthopedicsBiomedical Engineering
2015English

PARP Inhibitor Treatment in Ovarian and Breast Cancer

Current Problems in Cancer
Cancer ResearchOncology
2011English

Lysophosphatidic Acid Protects Cancer Cells From Histone Deacetylase (HDAC) Inhibitor-Induced Apoptosis Through Activation of HDAC

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2008English

An HDAC Inhibitor Increases AcMNPV Gene Expression in Mammalian Cells

Archives of Virology
MedicineVirology
2010English

The Novel Chk1 Inhibitor MK-8776 Sensitizes Human Leukemia Cells to HDAC Inhibitors by Targeting the Intra-S Checkpoint and DNA Replication and Repair

Molecular Cancer Therapeutics
Cancer ResearchOncology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy